ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Subgroup Analyses and Clinical Insights in Metastatic Hormone-Sensitive Prostate Cancer Treatment"
Episode Synopsis
Jack R. Andrews, MD; Eugene B. Cone MD; and Edwin Posadas, MD, FACP, discuss how early intervention with individualized treatment approaches based on disease volume, patient characteristics, and biomarkers significantly improves survival outcomes in metastatic hormone-sensitive prostate cancer.
Timecodes
1:35 Individualized Care for PC
9:24 Frailty & Comorbidities in PC
12:27 Molecular Testing in PC
18:10 Sequencing in PC
22:00 Doublets/Triplets in mHSPC
30:00 Subgroups in mHSPC
39:00 ARASENS Subgroup Analysis
43:55 Future of mHSPC Care
Timecodes
1:35 Individualized Care for PC
9:24 Frailty & Comorbidities in PC
12:27 Molecular Testing in PC
18:10 Sequencing in PC
22:00 Doublets/Triplets in mHSPC
30:00 Subgroups in mHSPC
39:00 ARASENS Subgroup Analysis
43:55 Future of mHSPC Care
More episodes of the podcast Urology Times Podcasts
Speaking of Urology: Patient-centered insights from the PKIDS trial in pediatric stone disease
09/10/2025
The Expert APProach: Training to Retain APPs in Urology, with J. Brandon Arruda, APRN, AGNP-C, CUNP
03/10/2025
Pearls & Perspectives: Theranostics and Beyond in Prostate Cancer, with Vahan Kassabian, MD
23/09/2025
In God we trust